Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Accumulated Expenses (2020 - 2026)

Biomea Fusion (BMEA) posted Accumulated Expenses of $3.4 million for Q1 2026, down 46.28% sequentially from $6.4 million in Q4 2025, and down 67.78% YoY from $10.7 million in Q1 2025.

Biomea Fusion (BMEA) Accumulated Expenses (2020 - 2026) Analysis & Trends

Biomea Fusion has reported Accumulated Expenses for 7 years, with the latest figure at $3.4 million in Q1 2026.

  • Quarterly Accumulated Expenses fell 67.78% year-over-year to $3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (down 67.78% YoY) and the FY2025 annual result came in at $6.4 million, down 3.83% from the prior year.
  • Accumulated Expenses eased to $3.4 million in Q1 2026 per BMEA's latest filing, from $6.4 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $17.4 million in Q1 2024 and troughed at $1.2 million in Q1 2022.
  • A 5-year average of $8.1 million and a median of $6.7 million in 2024 frame the typical range for Accumulated Expenses.
  • The sharpest annual moves came in 2024 and 2025: Accumulated Expenses jumped 870.35% in 2024, then slumped 81.51% in 2025.
  • Over 5 years, Accumulated Expenses stood at $11.7 million in 2022, then tumbled by 48.91% to $6.0 million in 2023, then gained by 11.85% to $6.7 million in 2024, then declined by 3.83% to $6.4 million in 2025, then sank by 46.28% to $3.4 million in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $3.4 million, $6.4 million, and $2.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Biomea Fusion 97.69 Mn 97.69 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 6.30 Mn
Mar 31, 2026 3.44 Mn
Dec 31, 2025 6.41 Mn
Sep 30, 2025 2.94 Mn
Jun 30, 2025 8.44 Mn
Mar 31, 2025 10.68 Mn
Dec 31, 2024 6.66 Mn
Sep 30, 2024 15.89 Mn
Jun 30, 2024 16.05 Mn
Mar 31, 2024 17.38 Mn
Dec 31, 2023 5.96 Mn
Sep 30, 2023 4.75 Mn
Jun 30, 2023 7.49 Mn
Mar 31, 2023 1.79 Mn
Dec 31, 2022 11.66 Mn
Sep 30, 2022 10.39 Mn
Jun 30, 2022 6.36 Mn
Mar 31, 2022 1.22 Mn
Dec 31, 2021 2.74 Mn
Sep 30, 2021 3.84 Mn